Above and Beyond Convenes First Neuromuscular Restoration Summit
Above and Beyond, a precision medicine company dedicated to discovering and translating new therapies for nervous system diseases at an accelerated pace, convened the Manhattan Neuromuscular Restoration Summit July 18-20, 2018 in New York.
» Read moreShifting aims: The First Neuromuscular Restoration Summit
In July 2018, Above and Beyond Concierge Therapeuticsconvened the first Manhattan Neuromuscular Restoration Summit in New York City. The Summit brought together academic and industry thought leaders and expert research scientists all dedicated to patient-focused solutions in the area of neurodegenerative diseases, nerve-based trauma, stem cells and neuro-engineering.
» Read moreInsilico Medicine (Insilico is an Above and Beyond collaborator) to Use Artificial Intelligence Platform to Discover New ALS Therapies
Insilico Medicine has launched ALS.AI, a drug discovery platform for new amyotrophic lateral sclerosis (ALS) treatments. It uses a powerful new analytical approach involving “deep learning” to seek out new therapies for the disease — and to evaluate whether existing drugs used to treat other diseases can be repurposed for treating ALS.
» Read more